The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis
Status:
Terminated
Trial end date:
2019-08-21
Target enrollment:
Participant gender:
Summary
The investigators postulate that F-18 florbetapir will show improved detection of cardiac
amyloidosis over conventional non-invasive imaging techniques, particularly in early disease.